CA2340616A1 - Proteines secretees et polynucleotides codant pour ces proteines - Google Patents

Proteines secretees et polynucleotides codant pour ces proteines Download PDF

Info

Publication number
CA2340616A1
CA2340616A1 CA002340616A CA2340616A CA2340616A1 CA 2340616 A1 CA2340616 A1 CA 2340616A1 CA 002340616 A CA002340616 A CA 002340616A CA 2340616 A CA2340616 A CA 2340616A CA 2340616 A1 CA2340616 A1 CA 2340616A1
Authority
CA
Canada
Prior art keywords
seq
nucleotide sequence
nucleotide
amino acid
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002340616A
Other languages
English (en)
Inventor
Dario Valenzuela
Olive Yuan
Heidi Hoffman
Jeff Hall
Peter Rapiejko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alphagene Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2340616A1 publication Critical patent/CA2340616A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides ainsi que les protéines codées par ces polynucléotides.
CA002340616A 1998-08-24 1999-08-24 Proteines secretees et polynucleotides codant pour ces proteines Abandoned CA2340616A1 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US9765998P 1998-08-24 1998-08-24
US9763898P 1998-08-24 1998-08-24
US9961898P 1998-09-09 1998-09-09
US10209298P 1998-09-28 1998-09-28
US10997898P 1998-11-25 1998-11-25
US11364598P 1998-12-23 1998-12-23
US11364698P 1998-12-23 1998-12-23
US37924699A 1999-08-23 1999-08-23
US60/097,638 1999-08-23
US60/113,646 1999-08-23
US60/097,659 1999-08-23
US09/379,246 1999-08-23
US60/109,978 1999-08-23
US60/099,618 1999-08-23
US60/113,645 1999-08-23
US60/102,092 1999-08-23
PCT/US1999/019351 WO2000011015A1 (fr) 1998-08-24 1999-08-24 Proteines secretees et polynucleotides codant pour ces proteines

Publications (1)

Publication Number Publication Date
CA2340616A1 true CA2340616A1 (fr) 2000-03-02

Family

ID=27574713

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340616A Abandoned CA2340616A1 (fr) 1998-08-24 1999-08-24 Proteines secretees et polynucleotides codant pour ces proteines

Country Status (5)

Country Link
EP (1) EP1107978A1 (fr)
JP (1) JP2002537757A (fr)
AU (1) AU5784799A (fr)
CA (1) CA2340616A1 (fr)
WO (1) WO2000011015A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030054400A1 (en) * 1997-09-17 2003-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7417126B2 (en) 1997-10-17 2008-08-26 Genentech, Inc. PRO246 antibodies
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
JP2003534767A (ja) * 1998-11-20 2003-11-25 アリーナ・フアーマシユーチカルズ・インコーポレーテツド ヒトオーファンｇタンパク質共役型受容体
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
EP1159413A4 (fr) * 1999-02-26 2005-12-14 Millennium Pharm Inc Proteines secretees et utilisations
ATE348108T1 (de) * 1999-03-08 2007-01-15 Genentech Inc Methode zum nachweis von tumoren
EP1189944A4 (fr) * 1999-06-21 2002-09-11 Smithkline Beecham Corp Axor16, r cepteur coupl une prot ine g
EP1207201A4 (fr) * 1999-08-27 2003-03-12 Takeda Chemical Industries Ltd Proteine recepteur couplee a une proteine g et adn correspondant
AU7452300A (en) * 1999-10-01 2001-05-10 Kyowa Hakko Kogyo Co. Ltd. Shear stress-response dna
WO2001025444A2 (fr) * 1999-10-07 2001-04-12 Zymogenetics, Inc. Nouvelle phosphodiesterase humaine: zcytor13
AU2055401A (en) * 1999-12-01 2001-06-12 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001087930A2 (fr) * 2000-05-18 2001-11-22 Bayer Aktiengesellschaft Regulation du recepteur couple a la proteine g analogue au recepteur de la galanine humaine
AU2001263105A1 (en) 2000-05-18 2001-11-26 Lexicon Genetics Incorporated Human semaphorin homologs and polynucleotides encoding the same
WO2002004518A2 (fr) * 2000-07-06 2002-01-17 Bayer Corporation Recepteur humain couple aux proteines g de type neuropeptide y
WO2002074237A2 (fr) * 2001-03-19 2002-09-26 Corixa Corporation Compositions et procedes de therapie et de diagnostic du cancer du rein
EP1293569A3 (fr) * 2001-09-14 2004-03-31 Research Association for Biotechnology Clones d'ADNc complets
JP2003088388A (ja) 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk 新規な全長ｃＤＮＡ
GB2397577A (en) * 2001-11-01 2004-07-28 Amersham Plc Human angiomotin-like protein 1
CN1324047C (zh) 2002-04-12 2007-07-04 先灵公司 G蛋白偶联受体的配体与方法
AU2003261874A1 (en) * 2002-09-02 2004-03-29 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
FR2848569A1 (fr) * 2002-12-17 2004-06-18 Exonhit Therapeutics Sa Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
WO2004106935A2 (fr) * 2003-05-27 2004-12-09 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur 103 couples aux proteines g (gpr103)
EP1733743A4 (fr) * 2004-04-09 2007-06-27 Takeda Pharmaceutical Agents de prevention/remedes contre le cancer
JPWO2005100566A1 (ja) 2004-04-14 2008-03-06 萬有製薬株式会社 新規サルｇｐｒ１０３及びサルｑｒｆｐ並びにｇｐｒ１０３を用いた化合物の評価方法
CN101772572A (zh) * 2007-03-23 2010-07-07 新加坡科技研究局 提高神经前体细胞的迁移的方法
TR201910330T4 (tr) * 2013-07-30 2019-07-22 Sbi Biotech Co Ltd Anti-fosfolin d4 antikoru içeren ilaç.

Also Published As

Publication number Publication date
WO2000011015A1 (fr) 2000-03-02
EP1107978A1 (fr) 2001-06-20
JP2002537757A (ja) 2002-11-12
AU5784799A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
CA2340616A1 (fr) Proteines secretees et polynucleotides codant pour ces proteines
US20020193567A1 (en) Secreted proteins and polynucleotides encoding them
WO1998033916A2 (fr) Proteines secretees et polynucleotides codant celles-ci
EP0998490A2 (fr) Proteines secretees et polynucleotides les codant
WO1998055614A2 (fr) Proteines secretees et polynucleotides codant ces proteines
EP0973890A2 (fr) Proteines secretees et polynucleotides les codant
CA2306457A1 (fr) Proteines secretees et polynucleotides les codant
WO1998027205A2 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
CA2310214A1 (fr) Proteines secretees et polynucleotides les codant
CA2324492A1 (fr) Proteines secretees et polynucleotides les codant
CA2327551A1 (fr) Proteines secretees et polynucleotides les codant
WO1998032853A2 (fr) Proteines secretees et polynucleotides les codant
WO1998044113A1 (fr) Proteines secretees et polynucleotides les codant
CA2322732A1 (fr) Proteines secretees et polynucleotides les codant
CA2311683A1 (fr) Proteines secretees et polynucleotides les codant
WO1998041539A2 (fr) Proteines secretees et polynucleotides les codant
CA2309782A1 (fr) Proteines secretees et polynucleotides les codant
CA2305689A1 (fr) Proteines secretees et polynucleotides les codant
CA2325057A1 (fr) Proteines secretees et polynucleotides codant pour celles-ci
EP0948620A2 (fr) Proteines secretees et polynucleotides les codant
CA2318303A1 (fr) Proteines secretees et polynucleotides les codant
EP0996721A2 (fr) Proteines secretees et polynucleotides les codant
CA2324504A1 (fr) Proteines secretees et polynucleotides les codant
EP1003855A2 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2309624A1 (fr) Proteines secretees et polynucleotides codant ces proteines

Legal Events

Date Code Title Description
FZDE Dead